ARCHIVES

Aromasin Approved By FDA For ER+ Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

ACCC Comments On DRGs to Be Review By PROPAC

September 6, 1985

FDA Approves Taxotere For Node+ Breast Cancer

August 27, 2004

Sales of Smoking Cessation Aids Increase, Effectiveness Drops

October 25, 2002

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

July 26, 2013

Agriculture Dept. Asks clearinghouse To Consider Broader Risk Assessment Data

July 14, 1978

Study Finds Short Term Tests Predict Carcinogenicity

April 25, 1980